Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models
Authors
Keywords
-
Journal
Journal of Materials Chemistry B
Volume 5, Issue 30, Pages 6049-6057
Publisher
Royal Society of Chemistry (RSC)
Online
2017-07-05
DOI
10.1039/c7tb01370a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
- (2017) Pedram Rafiei et al. International Journal of Nanomedicine
- Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy
- (2017) Joseph M. Caster et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer
- (2017) Jing Tian et al. Nanomedicine-Nanotechnology Biology and Medicine
- Glutathione boosting the cytotoxicity of a magnetic platinum(iv) nano-prodrug in tumor cells
- (2016) Zhenzhu Zhu et al. Chemical Science
- Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles
- (2015) Kin Man Au et al. ACS Nano
- Aptamer-Functionalized Gold Nanoparticles As Photoresponsive Nanoplatform for Co-Drug Delivery
- (2014) Yi-Syun Shiao et al. ACS Applied Materials & Interfaces
- Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
- (2014) Shutao Guo et al. ACS Nano
- Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
- (2014) Lei Miao et al. ADVANCED FUNCTIONAL MATERIALS
- Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
- (2014) J. E. Lancet et al. BLOOD
- Recent Clinical Advances in Lung Cancer Management
- (2014) David H. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
- (2014) Longyan Liao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery
- (2014) Vincent Pavot et al. Nanomedicine
- Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity
- (2014) Manish Sethi et al. Nanoscale
- Nanoparticles for Combination Drug Therapy
- (2013) Liang Ma et al. ACS Nano
- The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
- (2013) Timothy C. Johnstone et al. INORGANIC CHEMISTRY
- New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer
- (2013) Joseph K. Salama et al. JOURNAL OF CLINICAL ONCOLOGY
- Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
- (2012) Yuanzeng Min et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
- (2012) Che-Ming Jack Hu et al. BIOCHEMICAL PHARMACOLOGY
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- What do we know about the reduction of Pt(IV) pro-drugs?
- (2012) Ezequiel Wexselblatt et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Tracking T-cells in vivo with a new nano-sized MRI contrast agent
- (2012) Li Liu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration
- (2011) Boitumelo Semete et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Non-small-cell lung cancer
- (2011) Peter Goldstraw et al. LANCET
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
- (2011) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
- (2010) N. Kolishetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
- (2009) Francesca Greco et al. ADVANCED DRUG DELIVERY REVIEWS
- Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started